FDA — authorised 15 December 2008
- Application: NDA022311
- Marketing authorisation holder: GENZYME
- Local brand name: MOZOBIL
- Indication: SOLUTION — SUBCUTANEOUS
- Status: approved
🇺🇸 Weight-Based Plerixafor in United States
FDA authorised Weight-Based Plerixafor on 15 December 2008
Marketing authorisations
FDA
- Status: approved
Weight-Based Plerixafor in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Weight-Based Plerixafor approved in United States?
Yes. FDA authorised it on 15 December 2008; FDA has authorised it.
Who is the marketing authorisation holder for Weight-Based Plerixafor in United States?
GENZYME holds the US marketing authorisation.